395 filings
Page 7 of 20
CORRESP
p60xy6benkjsyx9hh hd
3 Jan 20
Correspondence with SEC
12:00am
UPLOAD
yq5ttc5
19 Dec 19
Letter from SEC
12:00am
8-K
65sgrg3s
18 Dec 19
Departure of Directors or Certain Officers
4:23pm
8-K
cgwflcq yj
4 Dec 19
Ampio Provides Update on AP-013 Phase III Clinical Trial and Annual Meeting Conference Call Number
8:44am
8-K
keey6os012q525
29 Oct 19
Entry into a Material Definitive Agreement
12:00am
8-K
9pdic4pt 41lxbucg
10 Oct 19
Ampio Provides Update on Continued Progress of AP-013 Phase III Clinical Trial and Manufacturing Facility
4:01pm
8-K
xewvb 35ico
20 Sep 19
Departure of Directors or Certain Officers
4:02pm
8-K
ztcoxy
23 Aug 19
Departure of Directors or Certain Officers
4:02pm
8-K
73hue n78q7h6ymghyc6
11 Jul 19
Changes in Registrant's Certifying Accountant
4:01pm
8-K
963dj1w
10 Jul 19
Ampio Appoints Dan Stokely as the Company’s new Chief Financial Officer
4:02pm
8-K
ti5l 51pxpg5lm
19 Jun 19
Ampio Pharmaceuticals Announces Closing of $12 Million Public Offering
4:01pm
8-K
dl0c9s5rl5
17 Jun 19
Ampio Pharmaceuticals Announces Pricing of Public Offering
9:23am
424B5
6ws0l dlh
17 Jun 19
Prospectus supplement for primary offering
8:21am
424B5
k3a94
17 Jun 19
Prospectus supplement for primary offering
6:04am
424B5
2y2x60 qbifg6
17 Jun 19
Prospectus supplement for primary offering
12:00am
8-K
cykst
14 Jun 19
Ampio Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
4:02pm